Core One Labs Applauds TheraPsil on Its Submission to Health Canada
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”) a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy, applauds TheraPsil, a B.C. based non-profit organization which advocates for the therapeutic use of the psychedelic compound […]
